{"entity":{"id":"inca","kind":"institution","name":"Institut National du Cancer","aka":["INCa","French National Cancer Institute"],"tldr":"France's national cancer agency, which steers the national cancer strategy and funds and labels research, trial networks and early-phase units.","summary":"Created by the 2004 public health law as the operational arm of the first Plan Cancer, INCa is a public interest group under the health and research ministries. It coordinates the ten-year national cancer strategy, funds research through calls such as PAIR and PHRC-K, labels the SIRIC integrated research sites and the CLIP² early-phase trial network, and ran the AcSé programme that gave patients access to targeted drugs outside their approved indication based on molecular profile. It publishes national guidelines, screening programmes and cancer statistics with Santé publique France.","asOf":"2026-09-09","links":[{"label":"Homepage","url":"https://www.cancer.fr"},{"label":"Research","url":"https://www.cancer.fr/professionnels-de-la-recherche"}],"tags":[],"related":[],"cancers":[],"sections":["prevention","early-detection"],"technologies":[],"targets":[],"drugs":[],"companies":["unicancer"],"institutions":["gustave-roussy","institut-curie","iarc"],"pathways":[],"terms":["tumour-agnostic","basket-umbrella-platform"],"trials":[],"people":["suzette-delaloge","nicolas-scotte"],"bottlenecks":["b-trial-enrolment","b-funding-allocation","b-early-detection"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Boulogne-Billancourt","country":"FR","lat":48.835,"lng":2.24,"institutionType":"government","website":"https://www.cancer.fr","programs":["National cancer strategy","SIRIC sites","CLIP² early-phase network","AcSé access programme","Screening and guidelines"]},"route":"/institutions/inca/","neighbours":{"section":[{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"},{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"company":[{"id":"unicancer","kind":"company","name":"UNICANCER","route":"/companies/unicancer/"}],"institution":[{"id":"gustave-roussy","kind":"institution","name":"Gustave Roussy","route":"/institutions/gustave-roussy/"},{"id":"institut-bergonie","kind":"institution","name":"Institut Bergonié","route":"/institutions/institut-bergonie/"},{"id":"institut-curie","kind":"institution","name":"Institut Curie","route":"/institutions/institut-curie/"},{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"}],"term":[{"id":"basket-umbrella-platform","kind":"term","name":"Basket, umbrella, and platform trials","route":"/terms/basket-umbrella-platform/"},{"id":"tumour-agnostic","kind":"term","name":"Tumour-agnostic (tissue-agnostic) approval","route":"/terms/tumour-agnostic/"}],"person":[{"id":"nicolas-scotte","kind":"person","name":"Nicolas Scotté","route":"/people/nicolas-scotte/"},{"id":"pierre-laurent-puig","kind":"person","name":"Pierre Laurent-Puig","route":"/people/pierre-laurent-puig/"},{"id":"suzette-delaloge","kind":"person","name":"Suzette Delaloge","route":"/people/suzette-delaloge/"}],"bottleneck":[{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"},{"id":"b-early-detection","kind":"bottleneck","name":"The hardest cancers are found late","route":"/bottlenecks/b-early-detection/"},{"id":"b-trial-enrolment","kind":"bottleneck","name":"Trials enrol too few, too slowly","route":"/bottlenecks/b-trial-enrolment/"}]}}